Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

3 Bio Companies Facing The Patent Cliff
Seeking Alpha
Tue, 05/7/13 - 05:31 pm
Tags:
patents, patent cliff, AbbVie, BiogenIdec, Eisai, JNJ, Eli Lilly, Novartis, Sanofi, Roche
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Marketwatch
Mon, 05/6/13 - 11:34 am
Tags:
FDA, breakthrough therapies, hepatitis C, AbbVie
The New Abbott Labs Is Leaner, but Needs Better Execution
TheStreet.com
Fri, 05/3/13 - 08:49 am
Tags:
Abbott Laboratories, AbbVie, JNJ
AbbVie Earnings Call Nuggets: Growth Guidance and Drug Candidates
Wall Street Cheat Street
Sun, 04/28/13 - 12:21 pm
Tags:
AbbVie, earnings
AbbVie delivers on scorching Humira drug sales growth
Reuters
Fri, 04/26/13 - 10:48 am
Tags:
earnings, AbbVie
How Will AbbVie's Earnings Fare?
Motley Fool
Thu, 04/25/13 - 09:22 am
Tags:
AbbVie, earnings
AbbVie hepatitis C drugs knock out virus at 8 weeks
Reuters
Tue, 04/23/13 - 07:50 am
Tags:
hepatitis C, AbbVie, ABT-450, ABT-333, ABT-267
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tue, 04/16/13 - 11:55 am
Tags:
sofosbuvir, Achillion, AbbVie, Bristol-Myers Squibb, Gilead, Merck, Idenix
Sales Reps Overboard: AbbVie To Layoff Hundreds
Pharmalot
Tue, 04/16/13 - 11:40 am
Tags:
drug reps, layoffs, AbbVie
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Fri, 04/12/13 - 09:48 am
Tags:
Celgene, apremilast, AbbVie, Amgen, JNJ, Humira, Stelara, psoriasis, Enbrel
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
Tags:
immuno-oncology, cancer, Bristol-Myers Squibb, AbbVie, Ariad Pharmaceuticals, JNJ, Eli Lilly, Novartis, Pfizer, Medivation, Erbitux, Yervoy, Sprycel, Orencia
This Week in Biotech
Motley Fool
Sun, 04/7/13 - 10:55 am
Tags:
JNJ, Optimer, Biogen, Merck, Cubist Pharmaceuticals, AstraZeneca, Rigel Pharmaceuticals, AbbVie, Pfizer
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Fri, 04/5/13 - 10:21 am
Tags:
Merck, Endocyte, Eli Lilly, Pfizer, Repligen, AbbVie, Protalix BioTherapeutics
Biogen Idec up after positive MS drug study
Marketwatch
Thu, 04/4/13 - 01:54 pm
Tags:
Biogen Idec, MS, multiple sclerosis, AbbVie, daclizumab
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
Tags:
investors, psoriasis, Amgen, Eli Lilly, Pfizer, Novartis, Celgene, Humira, AbbVie, Stelara, Remicade, Enbrel, apremilast, brodalumab, Xeljanz
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Mon, 04/1/13 - 10:38 am
Tags:
Amgen, AbbVie, Bristol-Myers Squibb, JNJ, Merck, Eli Lilly, Pfizer
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Tags:
Celgene, Revlimid, Multiple Myeloma, JNJ, Velcade, AbbVie, Bristol-Myers Squibb, elotuzumab
3 Attractive Healthcare Dividend Stocks
Motley Fool
Fri, 03/29/13 - 11:17 am
Tags:
AbbVie, dividend, AstraZeneca
How Safe is AbbVie from Niacin’s Woes?
Motley Fool
Thu, 03/21/13 - 11:12 am
Tags:
AbbVie, niacin, Niaspan, Merck, Biogen Idec, Neurocrine

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.